Gentex Hits Estimates in Solid Quarter

Tags: 2013 Great Stocks ,2013 Health Stocks ,Great Health Stocks To Buy ,Euro Vs. U.S. Dollar

Gentex (Nasdaq: GNTX  ) reported earnings yesterday. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Gentex met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded significantly, and GAAP earnings per share improved.

Margins dropped across the board.

Revenue details
Gentex booked revenue of $290.7 million. The nine analysts polled by S&P Capital IQ wanted to see revenue of $294.2 million on the same basis. GAAP reported sales were 16% higher than the prior-year quarter's $250.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.32. The 10 earnings estimates compiled by S&P Capital IQ forecast $0.32 per share. GAAP EPS of $0.32 for Q1 were 10% higher than the prior-year quarter's $0.29 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 34.7%, 130 basis points worse than the prior-year quarter. Operating margin was 22.5%, 140 basis points worse than the prior-year quarter. Net margin was 15.9%, 100 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $288.5 million. On the bottom line, the average EPS estimate is $0.30.

Next year's average estimate for revenue is $1.18 billion. The average EPS estimate is $1.28.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 135 members rating the stock outperform and 15 members rating it underperform. Among 34 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 32 give Gentex a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Gentex is outperform, with an average price target of $30.86.

Can your portfolio provide you with enough income to last through retirement? You'll need more than Gentex. Learn how to maximize your investment income and "Secure Your Future With 11 Rock-Solid Dividend Stocks." Click here for instant access to this free report.

Add Gentex to My Watchlist.